MedTrace Logo

Phenomics in Autoimmune and Inflammatory Diseases

NCT02466217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 537

Last updated 2023-08-08

No results posted yet for this study

Summary

The family of inflammatory/autoimmune systemic diseases (IAD) form a continuum from pure inflammatory diseases to pure autoimmune diseases, encompassing a large panel of inflammatory diseases with some autoimmune components, and vice versa. Cross phenotyping of patients with IAD should be heuristic and help revise the nosography and the understanding of these diseases.

Conditions

Interventions

OTHER

1: AID groups

Clinical and Biological investigations

OTHER

2: Control groups

Clinical and Biological investigations

Sponsors & Collaborators

  • National Research Agency, France

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • David KLATZMANN, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-29
Primary Completion
2022-07-14
Completion
2022-07-18

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466217 on ClinicalTrials.gov